Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Teresa P DiLorenzo
Affiliation
Universidad Cardenal Herrera-CEU, CEU Universities
ORCID
Career Start Year
1989
Papers
78
H Index
35
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36778569
A SARS-CoV-2 full genome sequence of the B.1.1 lineage sheds light on viral evolution in Sicily in late 2020.
Front Public Health
2023
34847567
An autoimmune stem-like CD8 T cell population drives type 1 diabetes.
Nature
2022
36224622
Detection of SARS-CoV-2 in a dog with hemorrhagic diarrhea.
BMC Vet Res
2022
34044020
Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again.
J Biol Chem
2021
34529725
A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
PLoS One
2021
32561620
T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal.
Diabetes
2020
31010879
The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes.
Diabetes
2019
31356169
Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
Immunohorizons
2019
29632144
HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression.
J Immunol
2018
29472249
Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.
Diabetes
2018
26754738
Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.
Immunogenetics
2016
26412590
Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses.
Mol Ther
2016
27124592
Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.
Immunology
2016
27150089
Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Methods Mol Biol
2016
26824049
An HLA-Transgenic Mouse Model of Type 1 Diabetes That Incorporates the Reduced but Not Abolished Thymic Insulin Expression Seen in Patients.
J Diabetes Res
2016
25302633
Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.
Clin Exp Immunol
2015
25333865
Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
Immunology
2015
25063871
Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.
J Immunol
2014
24021877
DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⺠T cells independently of PD-1 and PD-L1.
Int Immunol
2013
22539795
Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.
J Immunol
2012
21825122
Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
Proc Natl Acad Sci U S A
2011
22069259
Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens.
Diabetes Metab Res Rev
2011
20093428
Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.
Int Immunol
2010
21039471
T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes.
Immunology
2010
20979558
An update on the use of NOD mice to study autoimmune (Type 1) diabetes.
Expert Rev Clin Immunol
2010
20491789
The immunotherapeutic potential of dendritic cells in type 1 diabetes.
Clin Exp Immunol
2010
20404836
Autoimmunity. The benefit of self-control.
Immunol Cell Biol
2010
19966211
Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.
J Immunol
2010
20012396
Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
Methods Mol Biol
2010
19112449
Lentivectors encoding immunosuppressive proteins genetically engineer pancreatic beta-cells to correct diabetes in allogeneic mice.
Gene Ther
2009
18184707
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
J Virol
2008
19120273
HLA class I supertypes in type 1 diabetic children in an urban children's hospital.
Ann N Y Acad Sci
2008
18782577
Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities.
J Immunol Methods
2008
18439618
Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.
J Immunol Methods
2008
18430797
Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
Proc Natl Acad Sci U S A
2008
18358785
Identification of novel IGRP epitopes targeted in type 1 diabetes patients.
Clin Immunol
2008
17237389
Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator.
J Immunol
2007
18040044
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function.
Proc Natl Acad Sci U S A
2007
18058037
Structural genomics of protein phosphatases.
J Struct Funct Genomics
2007
17620420
In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Diabetes
2007
17349009
Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.
Clin Exp Immunol
2007
17376821
"Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Ann N Y Acad Sci
2007
17363302
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface.
Immunity
2007
16229893
Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation.
Mol Immunol
2006
16493087
HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
J Immunol
2006
15790363
The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
Immunol Rev
2005
15937548
Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
J Clin Invest
2005
14707058
MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
J Immunol
2004
15557165
Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
J Immunol
2004
15294969
Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
J Immunol
2004
1 - 50 of 78
Column Actions
Search
Recommended Authors
Thomas A Packard
J. David Gladstone Institutesgrid.249878.8
Career Start Year
2011
Number of shared co-authors
0
Cate Speake
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
2009
Number of shared co-authors
1
Howard R Seay
College of Medicine, Diabetes Institute, University of Florida
Career Start Year
2007
Number of shared co-authors
2
Jonathan L Linehan
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Todd M Brusko
College of Medicine, Diabetes Institute, University of Florida
Career Start Year
2003
Number of shared co-authors
2
Johnna D Wesley
Novo Nordisk Research Center Seattle, Inc.
Career Start Year
2003
Number of shared co-authors
1
Junbao Yang
Benaroya Research Institute
Career Start Year
2003
Number of shared co-authors
1
Sarah Alice Long
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1999
Number of shared co-authors
2
Jane H Buckner
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1995
Number of shared co-authors
2
Hui-Chen Hsu
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year
1993
Number of shared co-authors
1
Vivian H Gersuk
Center for Systems Immunology, Benaroya Research Institute
Career Start Year
1993
Number of shared co-authors
1
Qi Wu
University of Michigan Medical School
Career Start Year
1989
Number of shared co-authors
0
Michael J Clare-Salzler
University of Florida College of Medicine
Career Start Year
1989
Number of shared co-authors
0
Ursula Grohmann
University of Perugia
Career Start Year
1988
Number of shared co-authors
1
Chyung-Ru Wang
Feinberg School of Medicine, Northwestern University
Career Start Year
1987
Number of shared co-authors
0
Drake Laface
Merck & Co. Inc.
Career Start Year
1987
Number of shared co-authors
1
Karen Cerosaletti
Center for Translational Immunology
Career Start Year
1985
Number of shared co-authors
2
Kevan C Herold
Yale University
Career Start Year
1983
Number of shared co-authors
3
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1982
Number of shared co-authors
3
Penelope A Morel
University of Pittsburgh
Career Start Year
1982
Number of shared co-authors
0
Peter S Linsley
8Benaroya Research Institute
Career Start Year
1978
Number of shared co-authors
1
Carla J Greenbaum
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1977
Number of shared co-authors
2
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year
1976
Number of shared co-authors
5
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year
1975
Number of shared co-authors
0
Helena Reijonen
City of Hope Medical Center, Beckman Research Institute
Career Start Year
1973
Number of shared co-authors
1
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1971
Number of shared co-authors
1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1970
Number of shared co-authors
0
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1966
Number of shared co-authors
1
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year
1966
Number of shared co-authors
0
David W Scott
University of British Columbia
Career Start Year
1965
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Steven C Almo
Albert Einstein College of Medicine
Co-authored papers
7
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Co-authored papers
5
Vladimir N Malashkevich
Albert Einstein College of Medicine
Co-authored papers
3
Donald F Hunt
University of Virginia
Co-authored papers
3
Jeffrey Shabanowitz
University of Virginia
Co-authored papers
3
Leonard D Shultz
The Jackson Laboratory Cancer Center
Co-authored papers
2
John Sidney
Co-authored papers
2
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Co-authored papers
2
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers
2
Alicja Trocha
Ragon Institute of MGH
Co-authored papers
1
Stephen K Burley
The State University of New Jersey
Co-authored papers
1
Zhong-Yin Zhang
Center for Cancer Research, and Institute for Drug Discovery, Purdue University
Co-authored papers
1
Ragumani Sugadev
Defence Institute of Physiology and Allied Sciences (DIPAS)
Co-authored papers
1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
1
Michael Brenowitz
Albert Einstein College of Medicine
Co-authored papers
1
Joana Faber-Barata
Faculdade de Farmacia, Universidade Federal do Rio de Janeiro
Co-authored papers
1
Otto O Yang
Co-authored papers
1
Deborah Palliser
Albert Einstein College of Medicine
Co-authored papers
1
Cathleen Lutz
JAX Center for Precision Genetics
Co-authored papers
1
Joseph A Katakowski
Pfizer Inc.
Co-authored papers
1
Zhidong Tu
Co-authored papers
1
Laura Santambrogio
Weill Cornell School of Medicine
Co-authored papers
1
Paul Zumbo
Co-authored papers
1
J S Emtage
Co-authored papers
1
Jeffrey B Bonanno
Albert Einstein College of Medicine
Co-authored papers
1
J Michael Sauder
Eli Lilly and Co.
Co-authored papers
1
Bruce D Walker
Ragon Institute of Mass General
Co-authored papers
1
Haiteng Deng
Co-authored papers
1
Salvatore Sechi
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers
1
Nicholas D Socci
Co-authored papers
1
1 - 30